# A Kynurenine Pathway-based Molecular Imaging Study of Individualized Diagnosis and Treatment for Major Depressive Disorder

> **NCT04208932** · — · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 440 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** SSRIs

## Key facts

- **NCT ID:** NCT04208932
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-12
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2019-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04208932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04208932, "A Kynurenine Pathway-based Molecular Imaging Study of Individualized Diagnosis and Treatment for Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04208932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*